RT Journal Article
SR Electronic
T1 The importance of increasing primary vaccinations against COVID-19 in Europe
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.01.09.23284297
DO 10.1101/2023.01.09.23284297
A1 Boëlle, Pierre-Yves
A1 Valdano, Eugenio
YR 2023
UL http://medrxiv.org/content/early/2023/01/09/2023.01.09.23284297.abstract
AB In the European Union, mass vaccination against COVID-19 staved off the strict restrictions that had characterized early epidemic response. Now, vaccination campaigns are focusing on booster doses, and primary vaccinations have all but halted. Still, 52 million European adults are unvaccinated. We investigated if reaching the still unvaccinated population in future vaccination campaigns would substantially decrease the current burden of COVID-19, which is substantial. We focused on vaccination homophily, whereby those who are unvaccinated are mostly in contact with other unvaccinated, making COVID-19 circulation easier. We quantified vaccination homophily and estimated its impact on COVID-19 circulation.We used an online survey of 1,055,286 people from 22 European countries during early 2022. We computed vaccination homophily as the association between reported vaccination status and perceived vaccination uptake among one’s own social contacts, using a case-referent design and a hierarchical logistic model. We used this information in an analysis of the COVID-19 reproduction ratio to determine the impact of vaccine homophily in transmission.Vaccination homophily was present and strong everywhere: the average odds ratio of being vaccinated for a 10-percentage-point increase in coverage among contacts was 1.66 (95% CI=(1.60, 1.72)). Homophily was positively associated with the strictness of COVID-19-related restrictions in 2020 (Pearson=0.49, p-value=0.03). In the countries studied, 12%-to-18% of the reproduction ratio would be attributable to vaccine homophily.Reducing vaccination homophily may curb the reproduction ratio substantially even to the point of preventing recurrent epidemic waves. In addition to boosting those already vaccinated, increasing primary vaccination should remain a high priority in future vaccination campaigns, to reduce vaccination homophily: this combined strategy may decrease COVID-19 burden.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPartial support from EU grant MOOD (H2020-874850), ANR and Fondation de France - NoCOV (00105995), ANRS EMERGEN (ANRS0151) and Sorbonne Universite ISCD.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Access was obtained though a Data User Agreement between INSERM and University of Maryland, which reports the ethical approval of the IRB of the University of Maryland.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAccess to the survey data can be requested for research purposes at https://dataforgood.facebook.com/dfg/docs/covid-19-trends-and-impact-survey-request-for-data-access. The mixing matrices of household and non-household contacts are accessible at http://www.socialcontactdata.org/socrates/. Vaccination coverage data are accessible through the website of the European Centre for Disease Prevention and Control: https://www.ecdc.europa.eu/en/publications-data/data-covid-19-vaccination-eu-eea. The COVID-19 Government Response Tracker is accessible at https://www.bsg.ox.ac.uk/research/research-projects/covid-19-government-response-tracker